DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $32.00 at Stifel Nicolaus

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) had its price objective reduced by analysts at Stifel Nicolaus from $35.00 to $32.00 in a report released on Monday, Benzinga reports. The firm presently has a “hold” rating on the medical instruments supplier’s stock. Stifel Nicolaus’ price target suggests a potential upside of 14.24% from the company’s […]

Related Keywords

South Korea ,Korea ,William Blair ,Stifel Nicolau ,Stifel Nicolaus ,Envestnet Asset Management Inc ,Johnson Investment Counsel Inc ,Nasdaq ,Envestnet Portfolio Solutions Inc ,Goldman Sachs Group ,Company Profile ,Barrington Research ,Korea Investment ,Rafferty Asset Management ,Get Free Report ,Asset Management ,Portfolio Solutions ,Johnson Investment Counsel ,Investment Counsel ,Dentsply Sirona ,Nasdaq Xray ,Dxray ,Medical ,24903010 ,Lower Price Target ,